Crompton Greaves Consumer Electricals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 13, 2025, 9:36 pm

Competitors of Crompton Greaves Consumer Electricals Ltd

All Competitor Stocks of Crompton Greaves Consumer Electricals Ltd

Quarterly Result

Last Updated: May 31, 2025, 9:28 am

Below is a detailed analysis of the quarterly data for Crompton Greaves Consumer Electricals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 2,061.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,769.00 Cr. (Dec 2024) to 2,061.00 Cr., marking an increase of 292.00 Cr..
• For Expenses, as of Mar 2025, the value is 1,796.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,581.00 Cr. (Dec 2024) to 1,796.00 Cr., marking an increase of 215.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 264.00 Cr.. The value appears strong and on an upward trend. It has increased from 188.00 Cr. (Dec 2024) to 264.00 Cr., marking an increase of 76.00 Cr..
• For OPM %, as of Mar 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Dec 2024) to 13.00%, marking an increase of 2.00%.
• For Other Income, as of Mar 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Dec 2024) to 16.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 10.00 Cr..
• For Depreciation, as of Mar 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 38.00 Cr. (Dec 2024) to 40.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 231.00 Cr.. The value appears strong and on an upward trend. It has increased from 151.00 Cr. (Dec 2024) to 231.00 Cr., marking an increase of 80.00 Cr..
• For Tax %, as of Mar 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 26.00%.
• For Net Profit, as of Mar 2025, the value is 172.00 Cr.. The value appears strong and on an upward trend. It has increased from 112.00 Cr. (Dec 2024) to 172.00 Cr., marking an increase of 60.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.63. The value appears strong and on an upward trend. It has increased from 1.71 (Dec 2024) to 2.63, marking an increase of 0.92.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:32 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 12, 2025, 3:39 pm

Below is a detailed analysis of the balance sheet data for Crompton Greaves Consumer Electricals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 129.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 129.00 Cr..
• For Reserves, as of Mar 2025, the value is 3,261.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,871.00 Cr. (Mar 2024) to 3,261.00 Cr., marking an increase of 390.00 Cr..
• For Borrowings, as of Mar 2025, the value is 479.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 683.00 Cr. (Mar 2024) to 479.00 Cr., marking a decrease of 204.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,461.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,399.00 Cr. (Mar 2024) to 2,461.00 Cr., marking an increase of 62.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 6,330.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,082.00 Cr. (Mar 2024) to 6,330.00 Cr., marking an increase of 248.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 3,315.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,197.00 Cr. (Mar 2024) to 3,315.00 Cr., marking an increase of 118.00 Cr..
• For CWIP, as of Mar 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 58.00 Cr. (Mar 2024) to 14.00 Cr., marking a decrease of 44.00 Cr..
• For Investments, as of Mar 2025, the value is 721.00 Cr.. The value appears strong and on an upward trend. It has increased from 689.00 Cr. (Mar 2024) to 721.00 Cr., marking an increase of 32.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,279.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,137.00 Cr. (Mar 2024) to 2,279.00 Cr., marking an increase of 142.00 Cr..
• For Total Assets, as of Mar 2025, the value is 6,330.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,082.00 Cr. (Mar 2024) to 6,330.00 Cr., marking an increase of 248.00 Cr..

Notably, the Reserves (3,261.00 Cr.) exceed the Borrowings (479.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Crompton Greaves Consumer Electricals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 6.88. This value is within the healthy range. It has decreased from 7.29 (Mar 23) to 6.88, marking a decrease of 0.41.
• For Diluted EPS (Rs.), as of Mar 24, the value is 6.88. This value is within the healthy range. It has decreased from 7.27 (Mar 23) to 6.88, marking a decrease of 0.39.
• For Cash EPS (Rs.), as of Mar 24, the value is 8.87. This value is within the healthy range. It has decreased from 9.31 (Mar 23) to 8.87, marking a decrease of 0.44.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 53.63. It has increased from 48.86 (Mar 23) to 53.63, marking an increase of 4.77.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 53.63. It has increased from 48.86 (Mar 23) to 53.63, marking an increase of 4.77.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 113.71. It has increased from 108.00 (Mar 23) to 113.71, marking an increase of 5.71.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 12.15. This value is within the healthy range. It has decreased from 13.16 (Mar 23) to 12.15, marking a decrease of 1.01.
• For PBIT / Share (Rs.), as of Mar 24, the value is 10.14. This value is within the healthy range. It has decreased from 11.34 (Mar 23) to 10.14, marking a decrease of 1.20.
• For PBT / Share (Rs.), as of Mar 24, the value is 8.91. This value is within the healthy range. It has decreased from 9.62 (Mar 23) to 8.91, marking a decrease of 0.71.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 6.87. This value is within the healthy range. It has decreased from 7.49 (Mar 23) to 6.87, marking a decrease of 0.62.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 6.84. This value is within the healthy range. It has decreased from 7.28 (Mar 23) to 6.84, marking a decrease of 0.44.
• For PBDIT Margin (%), as of Mar 24, the value is 10.68. This value is within the healthy range. It has decreased from 12.18 (Mar 23) to 10.68, marking a decrease of 1.50.
• For PBIT Margin (%), as of Mar 24, the value is 8.91. This value is below the healthy minimum of 10. It has decreased from 10.50 (Mar 23) to 8.91, marking a decrease of 1.59.
• For PBT Margin (%), as of Mar 24, the value is 7.83. This value is below the healthy minimum of 10. It has decreased from 8.91 (Mar 23) to 7.83, marking a decrease of 1.08.
• For Net Profit Margin (%), as of Mar 24, the value is 6.04. This value is within the healthy range. It has decreased from 6.93 (Mar 23) to 6.04, marking a decrease of 0.89.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 6.01. This value is below the healthy minimum of 8. It has decreased from 6.74 (Mar 23) to 6.01, marking a decrease of 0.73.
• For Return on Networth / Equity (%), as of Mar 24, the value is 14.66. This value is below the healthy minimum of 15. It has decreased from 17.41 (Mar 23) to 14.66, marking a decrease of 2.75.
• For Return on Capital Employeed (%), as of Mar 24, the value is 16.23. This value is within the healthy range. It has decreased from 18.41 (Mar 23) to 16.23, marking a decrease of 2.18.
• For Return On Assets (%), as of Mar 24, the value is 7.23. This value is within the healthy range. It has decreased from 8.19 (Mar 23) to 7.23, marking a decrease of 0.96.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 0.2. It has decreased from 0.22 (Mar 23) to 0.09, marking a decrease of 0.13.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.19. This value is within the healthy range. It has decreased from 0.34 (Mar 23) to 0.19, marking a decrease of 0.15.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.25. It has increased from 1.14 (Mar 23) to 1.25, marking an increase of 0.11.
• For Current Ratio (X), as of Mar 24, the value is 1.31. This value is below the healthy minimum of 1.5. It has increased from 1.30 (Mar 23) to 1.31, marking an increase of 0.01.
• For Quick Ratio (X), as of Mar 24, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.87 (Mar 23) to 0.90, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.32. This value is below the healthy minimum of 4. It has decreased from 2.37 (Mar 23) to 2.32, marking a decrease of 0.05.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 43.62. This value is within the healthy range. It has increased from 34.19 (Mar 23) to 43.62, marking an increase of 9.43.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 33.74. This value is within the healthy range. It has increased from 27.35 (Mar 23) to 33.74, marking an increase of 6.39.
• For Earning Retention Ratio (%), as of Mar 24, the value is 56.38. This value is within the healthy range. It has decreased from 65.81 (Mar 23) to 56.38, marking a decrease of 9.43.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 66.26. This value is within the healthy range. It has decreased from 72.65 (Mar 23) to 66.26, marking a decrease of 6.39.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 9.86. This value is within the healthy range. It has increased from 7.67 (Mar 23) to 9.86, marking an increase of 2.19.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 6.58. This value is within the healthy range. It has increased from 5.36 (Mar 23) to 6.58, marking an increase of 1.22.
• For Enterprise Value (Cr.), as of Mar 24, the value is 17,971.18. It has decreased from 19,894.96 (Mar 23) to 17,971.18, marking a decrease of 1,923.78.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.46. This value is within the healthy range. It has decreased from 2.90 (Mar 23) to 2.46, marking a decrease of 0.44.
• For EV / EBITDA (X), as of Mar 24, the value is 23.01. This value exceeds the healthy maximum of 15. It has decreased from 23.76 (Mar 23) to 23.01, marking a decrease of 0.75.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.35. This value is within the healthy range. It has decreased from 2.71 (Mar 23) to 2.35, marking a decrease of 0.36.
• For Retention Ratios (%), as of Mar 24, the value is 56.37. This value is within the healthy range. It has decreased from 65.80 (Mar 23) to 56.37, marking a decrease of 9.43.
• For Price / BV (X), as of Mar 24, the value is 5.73. This value exceeds the healthy maximum of 3. It has decreased from 7.01 (Mar 23) to 5.73, marking a decrease of 1.28.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.35. This value is within the healthy range. It has decreased from 2.71 (Mar 23) to 2.35, marking a decrease of 0.36.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness